Cargando…
Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928643/ https://www.ncbi.nlm.nih.gov/pubmed/36819183 http://dx.doi.org/10.1002/jha2.606 |
| _version_ | 1784888687119564800 |
|---|---|
| author | Tseng, Chen I. Roddick, Alistair J. Bottomley, Matthew J. Shapiro, Susan Udayaraj, Udaya |
| author_facet | Tseng, Chen I. Roddick, Alistair J. Bottomley, Matthew J. Shapiro, Susan Udayaraj, Udaya |
| author_sort | Tseng, Chen I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9928643 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99286432023-02-16 Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis Tseng, Chen I. Roddick, Alistair J. Bottomley, Matthew J. Shapiro, Susan Udayaraj, Udaya EJHaem Correspondence John Wiley and Sons Inc. 2022-11-29 /pmc/articles/PMC9928643/ /pubmed/36819183 http://dx.doi.org/10.1002/jha2.606 Text en © 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondence Tseng, Chen I. Roddick, Alistair J. Bottomley, Matthew J. Shapiro, Susan Udayaraj, Udaya Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis |
| title | Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis |
| title_full | Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis |
| title_fullStr | Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis |
| title_full_unstemmed | Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis |
| title_short | Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis |
| title_sort | safety and pharmacokinetic profile of apixaban in end‐stage renal disease: a real‐world analysis |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928643/ https://www.ncbi.nlm.nih.gov/pubmed/36819183 http://dx.doi.org/10.1002/jha2.606 |
| work_keys_str_mv | AT tsengcheni safetyandpharmacokineticprofileofapixabaninendstagerenaldiseasearealworldanalysis AT roddickalistairj safetyandpharmacokineticprofileofapixabaninendstagerenaldiseasearealworldanalysis AT bottomleymatthewj safetyandpharmacokineticprofileofapixabaninendstagerenaldiseasearealworldanalysis AT shapirosusan safetyandpharmacokineticprofileofapixabaninendstagerenaldiseasearealworldanalysis AT udayarajudaya safetyandpharmacokineticprofileofapixabaninendstagerenaldiseasearealworldanalysis |